Jupiter Neurosciences Inc. (NASDAQ: JUNS) appointed Kristopher Fishman and Sanjiv Lal to the advisory board of its Nugevia consumer longevity product line, according to a company statement.

Fishman serves as CEO and President of Wells Pharmacy Network LLC, a compounding pharmacy licensed in 48 states that specializes in wellness and anti-aging products. The company operates both 503A compounding pharmacy and 503B outsourcing facilities in Florida and Tennessee.

Lal is co-founder and partner at Motivant, a healthcare scaling company, and co-founder of RegenTherapy, a regenerative medicine platform. He previously founded three laboratory businesses and held executive roles at Fortune 500 biotechnology companies. Lal holds bachelor's and master's degrees in pharmaceutical sciences from The Ohio State University.

Jupiter Neurosciences estimates the combined U.S. nutraceutical market for compounding pharmacies and wellness channels at over $1.5 billion. The company's Nugevia product line includes three formulations using its JOTROL micellar delivery technology: PWR for mitochondrial support, MND for cognitive health, and GLO for skin vitality.

The clinical-stage pharmaceutical company is developing treatments for central nervous system disorders and rare diseases. Jupiter Neurosciences has received FDA clearance for a Phase IIa clinical trial of its JOTROL platform in Parkinson's disease.

"Compounding pharmacies and wellness centers are staffed by practitioners who evaluate formulation science before recommending products to their patients and clients," said Christer Rosén, chairman and CEO of Jupiter Neurosciences.

The Nugevia products are currently available direct-to-consumer, and the company is expanding into practitioner-led distribution channels.